Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05127590
Title RBN-2397 in Combination With Pembrolizumab in Patients With SCCL
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ribon Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP

Facility Status City State Zip Country Details
Helen F. Graham Cancer Center (Christiana Care) Newark Delaware 19713 United States Details
Cancer Treatment Centers of America Newnan Georgia 30265 United States Details
Hematology and Oncology Clinic Baton Rouge Louisiana 70809 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Rambam Care Campus Haifa Israel Details
Hadassah Medical Center Jerusalem Israel Details
Shaare Zedek Medical Center Jerusalem Israel Details
Hospital Clinico Universitario De Santiago De Compostela A Coruña Spain Details
NEXT Oncology Barcelona Barcelona Spain Details
Vall D'Hebron Insitute of Oncology Barcelona Spain Details
Hospital Universitario Ramon Y Cajal Madrid Spain Details
Hospital Regional Universitario de Malaga Málaga Spain Details
Hospital Quiron Madrid Pozuelo de Alarcón Spain Details
Hospital Universitario Virgen Macarena Sevilla Spain Details
INCLIVA Biomedical Research Institute Valencia Spain Details
Beatson West of Scotland Cancer Centre Glasgow Scotland United Kingdom Details
Imperial College London London United Kingdom Details
Sarah Cannon Research Institute UK (University College London Hospitals) London United Kingdom Details
The Christie NHS Foundation Trust Manchester United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field